EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations

Yulong Li iD, William F Simonds iD, Haobin Chen iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae506 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Yulong Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Parathyroid Neoplasms, Adenoma, Germ-Line Mutation, Tumor Suppressor Proteins. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Parathyroid cancer has been linked to germline mutations of the Cell Division Cycle 73 (CDC73) gene. However, carriers harboring cancer-associated germline CDC73 mutations may develop only parathyroid adenoma or no parathyroid disease. This incomplete penetrance indicates that additional genomic events are required for parathyroid tumorigenesis.

Objective

(1) Determine the status of the second CDC73 allele in parathyroid tumors harboring germline CDC73 mutations and (2) compare the genomic landscapes between parathyroid carcinomas and adenomas.

Design

Whole-exome and RNA sequencing of 12 parathyroid tumors harboring germline CDC73 mutations (6 adenomas and 6 carcinomas) and their matched normal tissues.

Results

All 12 parathyroid tumors had gained 1 somatic event predicted to cause a complete inactivation of the second CDC73 allele. Several distinctive genomic features were identified in parathyroid carcinomas compared to adenomas, including more single nucleotide variants bearing the C > G transversion and APOBEC deamination signatures, frequent mutations of the genes involved in the PI-3K/mTOR signaling, a greater number of copy number variations, and substantially more genes with altered expression. Parathyroid carcinomas also share some genomic features with adenomas. For instance, both have recurrent somatic mutations and copy number loss that impact the genes involved in T-cell receptor signaling and tumor antigen presentation, suggesting a shared strategy to evade immune surveillance.

Conclusion

Biallelic inactivation of CDC73 is essential for parathyroid tumorigenesis in carriers harboring germline mutations of this gene. Despite sharing some genomic features with adenomas, parathyroid carcinomas have more distinctive alterations in the genome, some of which may be critical for cancer formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parathyroid NeoplasmsAdenomaGerm-Line MutationTumor Suppressor ProteinsCarcinomaHumansMaleFemaleMiddle AgedHeterozygoteGenomicsAdultAgedDNA Copy Number VariationsExome Sequencing

Stichwörter der Autor:innen

RNA sequencingcopy number alterationshyperparathyroidism-jaw tumor syndromewhole-exome sequencing

Substanzen

CDC73 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Division of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

ORCID-Profile: Yulong Li, William F Simonds, Haobin Chen

Förderung

  • Intramural NIH HHS
  • Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases
  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Li, Y., Simonds, W. F., & Chen, H. (2025). A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae506

Vancouver

Li Y, Simonds WF, Chen H. A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae506

BibTeX
@article{Li2025,
  author = {Li, Yulong and Simonds, William F and Chen, Haobin},
  title = {A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae506}
}
Kostenlos starten →